{"title":"Generation of Human Acute Lymphoblastic Leukemia Xenografts for Use in Oncology Drug Discovery","authors":"Linda Holmfeldt, Charles G. Mullighan","doi":"10.1002/0471141755.ph1432s68","DOIUrl":null,"url":null,"abstract":"<p>The establishment of reproducible mouse models of acute lymphoblastic leukemia (ALL) is necessary to provide in vivo therapeutic test systems that recapitulate human ALL, and for amplification of limited amounts of primary tumor material. A popular assay is the primary xenograft model that utilizes immunocompromised mice. The protocol includes injection of primary patient tumor specimens into mice with subsequent serial passaging of the tumors by retransplants of cells harvested from the mouse bone marrow and spleen. The tumors generated are then used for genomic profiling, ex vivo compound testing, mechanistic studies and retransplantation. Detailed in this unit are procedures for the establishment and maintenance of primary ALL xenograft panels for use in basic research and translational studies. © 2015 by John Wiley & Sons, Inc.</p>","PeriodicalId":10871,"journal":{"name":"Current Protocols in Pharmacology","volume":"68 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/0471141755.ph1432s68","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/0471141755.ph1432s68","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 6
Abstract
The establishment of reproducible mouse models of acute lymphoblastic leukemia (ALL) is necessary to provide in vivo therapeutic test systems that recapitulate human ALL, and for amplification of limited amounts of primary tumor material. A popular assay is the primary xenograft model that utilizes immunocompromised mice. The protocol includes injection of primary patient tumor specimens into mice with subsequent serial passaging of the tumors by retransplants of cells harvested from the mouse bone marrow and spleen. The tumors generated are then used for genomic profiling, ex vivo compound testing, mechanistic studies and retransplantation. Detailed in this unit are procedures for the establishment and maintenance of primary ALL xenograft panels for use in basic research and translational studies. © 2015 by John Wiley & Sons, Inc.
用于肿瘤药物发现的人类急性淋巴细胞白血病异种移植物的产生
建立可重复的急性淋巴细胞白血病(ALL)小鼠模型对于提供概括人类ALL的体内治疗试验系统以及扩增有限数量的原发肿瘤物质是必要的。一种流行的试验是利用免疫功能低下的小鼠进行原发异种移植模型。该方案包括将原发患者肿瘤标本注射到小鼠体内,随后通过从小鼠骨髓和脾脏中获取的细胞再移植,对肿瘤进行连续传代。产生的肿瘤随后被用于基因组分析、体外化合物测试、机制研究和再移植。本单元详细介绍了用于基础研究和转化研究的原发性ALL异种移植板的建立和维护程序。©2015 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。